UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.78 +0.76 (+0.97%) GOLD FUTURES
2,392.50 +32.60 (+1.38%) DOW
39,871.55 +313.44 (+0.79%) Bitcoin GBP
52,051.14 +3,473.68 (+7.15%)
AMRX Sep 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:47AM EDT. Market open.
| Previous close | 2.2000 |
| Open | 2.2000 |
| Bid | 2.0000 |
| Ask | 2.3000 |
| Strike | 5.00 |
| Expiry date | 2024-09-20 |
| Day's range | 2.2000 - 2.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 84 |
Simply Wall St.Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)
Amneal Pharmaceuticals ( NASDAQ:AMRX ) First Quarter 2024 Results Key Financial Results Revenue: US$659.2m (up 18% from...
- GuruFocus.com
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
Business WireAmneal Reports First Quarter 2024 Financial Results
BRIDGEWATER, N.J., May 03, 2024--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
© 2024 Yahoo. All rights reserved.